Celgene Acceleron to file MDS therapy in the EU US

Celgene and Acceleron Pharma are preparing to file their experimental myelodysplastic syndromes MDS therapy on both sides of the Atlantic on the back of promising data from a latestage study.
Read the full story: Bioportfolio Latest News